OTX-TP

Ocular's sustained-release insert misses bull's-eye in phase 3 glaucoma trial
Fierce Biotech
Tue, 05/21/19 - 09:59 am
Ocular Therapeutix
glaucoma
clinical trials
OTX-TP
3 Biotech Stocks With Upcoming Data That Could Be Huge
24/7 Wall St
Thu, 01/22/15 - 09:33 am
Aerie Pharma
Ocular Therapeutix
Xoma
gevokizumab
Rhopressa
OTX-TP